- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 40.52M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 25.6M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 3.26M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$55.29K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$73.68K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $1.47M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $1.44M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $168.47K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $345.11K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $37.02M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $22.74M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $6.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $7.75M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.27M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.4M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.12M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.26M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.35M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $45.14M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $31M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.24 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.24 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.23M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $507.18K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $83.76K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $29.59K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.14M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$785.57K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.12M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$758.62K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $285.49K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$136.06K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $698.05K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.27M |
| Revenue | Q1 2026 · Mar 31, 2026 | $983.54K |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.14M |
| Capex | Q1 2026 · Mar 31, 2025 | $58.32K |